Can-fite Biopharma Ltd. - Net Worth and Insider Trading

Can-fite Biopharma Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Can-fite Biopharma Ltd. owns 1 companies in total, including Mawson Infrastructure Group Inc (MIGI) .

Click here to see the complete history of Can-fite Biopharma Ltd.’s form 4 insider trades.

Insider Ownership Summary of Can-fite Biopharma Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
MIGI	Mawson Infrastructure Group Inc	2011-11-21	10 percent owner

Can-fite Biopharma Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Can-fite Biopharma Ltd. Ownership Network

Ownership Network List of Can-fite Biopharma Ltd.

No Data

Ownership Network Relation of Can-fite Biopharma Ltd.

Can-fite Biopharma Ltd. Owned Company Details

What does Mawson Infrastructure Group Inc do?

Who are the key executives at Mawson Infrastructure Group Inc?

Can-fite Biopharma Ltd. is the 10 percent owner of Mawson Infrastructure Group Inc. Other key executives at Mawson Infrastructure Group Inc include Principal Accounting Officer Ariel Humberto Sivikofsky , Chief Commercial Officer Nicholas Jeremy Hughes-jones , and Chief Financial Officer Hetal Majithia .

Mawson Infrastructure Group Inc (MIGI) Insider Trades Summary

Over the past 18 months, Can-fite Biopharma Ltd. made no insider transaction in Mawson Infrastructure Group Inc (MIGI). Other recent insider transactions involving Mawson Infrastructure Group Inc (MIGI) include a net sale of 48,395 shares made by Ryan Costello ,

In summary, during the past 3 months, insiders sold 48,395 shares of Mawson Infrastructure Group Inc (MIGI) in total and bought 0 shares, with a net sale of 48,395 shares. During the past 18 months, 48,395 shares of Mawson Infrastructure Group Inc (MIGI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 48,395 shares.

Mawson Infrastructure Group Inc (MIGI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mawson Infrastructure Group Inc Insider Transactions

No Available Data

Can-fite Biopharma Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Can-fite Biopharma Ltd.. You might contact Can-fite Biopharma Ltd. via mailing address: 10 Bareket Street, Kiryat Matalon, P.o. Box 7537, Petach Tikva L3 4951778.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.